Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...
Our interviewees this month describe the rewards and challenges of their complementary roles in antiviral drug discovery and ... how a compound with a new mechanism of action affects the lives ...
Scientists have found that an oral antiviral drug successfully prevents monkeys from dying after an Ebola infection, an ...
Antiviral drug development is now progressing at the pace antibiotics were 30 years ago. At present, there are some 60 antiviral drug preparations that have been approved by the US FDA ...
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
Hosted on MSN1y
Study describes structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCPA recent article in the journal Nature Communications describes the structural basis of mimicked HBV/HDV viral peptide drug interaction ... However, the exact mechanism of NTCP-mediated virus ...
This rather complex six-protein system is interesting because it combines classical DNA methylation with new antiviral mechanisms. In this study, we tried to find out how BREX distinguishes ...
Creative Diagnostics has announced its comprehensive Drug Discovery Services for antiviral therapeutic development. NEW YORK, NY, UNITED ST ...
The scope of his studies has ranged from antiviral mechanisms of action to clinical trials involving ... After her post-doctoral studies, Dr. Carter moved to PRAECIS Pharmaceuticals where she led drug ...
Efavirenz (EFV), brand-named drugs such as Sustiva, is an antiretroviral drug utilized mostly for HIV/AIDS treatment and prevention. Efavirenz is a category of drugs that fall under non-nucleoside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results